- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02531243
Computer-Aided Learning for Managing Stress (CALMS)
A Pilot Study of Computerized Biofeedback Games With Young People Experiencing Psychotic-Spectrum Symptoms
Study Overview
Detailed Description
CALMS revolves around the use of Emotional Manipulatives (EM) developed at Boston Children's Hospital (BCH). EM are single and multi-user biofeedback games designed to enhance executive control of emotion. The intervention and EM in CALMS were adapted from those used in Anger Control Training (ACT) with Regulate and Gain Emotional Control (RAGE-Control). In a randomized controlled trial at BCH, ACT and RAGE-Control relative to "sham" video-game play without biofeedback led to significantly greater reductions of aggression in adolescents and greater improvement in family functioning.
In this feasibility study, family dyads will participate in 12 sessions aimed at
- enhancing engagement through the use of video and other games,
- enhancing stress resilience through biofeedback, education, and individualized stress-reduction practice, and
- harnessing the power of the family to enhance contextual learning and the generality and duration of effects.
Clinical, self-report, and heart rate measures will be assessed at baseline, 4, 8, and 12 week assessments.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Currently Meet or Have Met Criteria of Prodromal Syndromes (COPS) according to the SIPS within the past 2 years
- Estimated IQ > 70
- Speak fluent English
- Have at least one parent or adult family member who also speaks fluent English and is willing to participate
Exclusion Criteria:
- Physical limitations precluding effective use of biofeedback videogames
- Co-morbid psychiatric disorders, including substance disorders, but only if they better explain COPS symptoms or make participation counter-indicated.
- Active suicidal ideation or attempts within the past 2 months unless being actively monitored and treated for this by a clinician
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CALMS
12 session family therapy using multi-user biofeedback games
|
Family Therapy; Multi-user Biofeedback Videogames
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility: Percent of referred who consent and meet study criteria
Time Frame: Up to six months
|
Enrollment
|
Up to six months
|
Feasibility: Percent of 12 sessions completed
Time Frame: Up to six months
|
Engagement: Percent of sessions completed by consented and eligible participants
|
Up to six months
|
Feasibility: Counts of premature termination of intervention
Time Frame: Up to six months
|
Up to six months
|
|
Feasibility: Self-report of Credibility/Satisfaction
Time Frame: 12 week assessment or last assessment completed
|
Individual and family member self-report
|
12 week assessment or last assessment completed
|
Feasibility: Self-report of User Experience
Time Frame: 12 week assessment or last assessment completed
|
Self-report of ability to learn/use technology to lower stress reactivity
|
12 week assessment or last assessment completed
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Perceived Stress relative to Baseline
Time Frame: Weeks 4, 8, and 12 Assessments
|
Self-report via Perceived Stress Scale
|
Weeks 4, 8, and 12 Assessments
|
Change relative to Baseline in Youth Perceptions of Relationship with Family Member
Time Frame: Weeks 4, 8, 12 Assessments
|
Self-report of conflict, criticism, and warmth in relationship with participating family member
|
Weeks 4, 8, 12 Assessments
|
Change relative to Baseline in Parent Perceptions of Relationship with Adolescent or Young Adult
Time Frame: Weeks 4, 8, 12 Assessments
|
Self-report of conflict, criticism, and warmth in relationship with youth
|
Weeks 4, 8, 12 Assessments
|
Positive Symptom Score Change relative to Baseline
Time Frame: Weeks 4,8, and 12 Assessments
|
Total positive symptom score according to the Structured Interview of Psychosis-risk Syndromes (SIPS)
|
Weeks 4,8, and 12 Assessments
|
Change in Social and Role Functioning relative to Baseline
Time Frame: Weeks 4, 8, and 12 Assessments
|
Global Functioning: Social & Role Scales;
|
Weeks 4, 8, and 12 Assessments
|
Change in Global Functioning relative to Baseline
Time Frame: Weeks 4, 8, and 12 Assessments
|
SIPS Global Assessment of Functioning
|
Weeks 4, 8, and 12 Assessments
|
Safety: Change in Hostility/Aggression relative to Baseline
Time Frame: Weeks 4, 8, and 12
|
Self-report
|
Weeks 4, 8, and 12
|
Safety: Change in Video-game Addiction relative to Baseline
Time Frame: Weeks 4, 8, and 12
|
Self-report
|
Weeks 4, 8, and 12
|
Difference in reaction times for emotional and calm faces on an Emotional Go/NoGo Task
Time Frame: Baseline, Weeks 4,8, and 12
|
Executive Control of Emotion
|
Baseline, Weeks 4,8, and 12
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kristen Woodberry, MSW, Ph.D., Beth Israel Deaconess Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012P000377
- K23MH102358 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosis
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of UdineNational Research Council (CNR), Institute of Biomolecular Chemistry (ICB)...RecruitingClinical High Risk for Psychosis | Ultra High Risk for Psychosis | Attenuated Psychotic SymptomsItaly
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Chulalongkorn UniversityNational Research Council of Thailand; Thanyarak InstituteCompletedMethamphetamine-induced PsychosisThailand
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaboratorsRecruitingSchizophrenia; Psychosis | Clinical High Risk | First Episode PsychosisChina
-
University of California, San DiegoCenter for Medicinal Cannabis ResearchRecruitingEarly PsychosisUnited States
-
Yale UniversityCompleted
-
University of TorontoUniversity of British Columbia; Centre for Addiction and Mental Health; Queen... and other collaboratorsNot yet recruitingPsychotic Disorders | Schizophrenia | Psychosis | Schizophrenia; Psychosis
-
Northwell HealthNational Institute of Mental Health (NIMH)RecruitingFirst Episode PsychosisUnited States
-
State reference center for psychosocial careUniversity of ValenciaCompleted